Lee Ho Young, Lee Jin, Lee Young Seok, Kim Mi-Yeong, Lee Hyun-Kyung, Lee Young-Min, Shin Jeong Hwan, Ko Yousang
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
Department Laboratory Medicine, Inje University Busan Paik Hospital, Busan, Korea.
Korean J Intern Med. 2015 May;30(3):325-34. doi: 10.3904/kjim.2015.30.3.325. Epub 2015 Apr 29.
BACKGROUND/AIMS: We evaluated the trend in the rates of drug-resistant tuberculosis (TB) over time, as well as the difference in the drug-resistance pattern between pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) at a private referral center in South Korea.
All patients with culture-confirmed TB from 2006 to 2013 were included.
In total, 1,745 patients were included: 1,431 (82.0%) were new cases, and 314 (18.0%) were cases treated previously; 1,610 (92.3%) were diagnosed with PTB, and 135 (7.7%) were diagnosed with EPTB. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB were detected in 5.8% and 2.0% of new cases and in 20.1% and 8.6% of previously treated cases, respectively. The MDR TB rate during the study period decreased remarkably, whereas the MDR and XDR TB rates decreased significantly in previously treated cases. No difference in the drug-resistance rate was detected between PTB and EPTB.
The TB drug-resistance rate, particularly that of MDR TB, remained high at a private referral hospital, and the drug-resistance rate did not decrease significantly from 2006 to 2013. This finding underscores the need for a national survey regarding the prevalence of drug-resistant TB to obtain the most accurate and current drug-resistance status in South Korea, including the private sector.
背景/目的:我们评估了韩国一家私立转诊中心耐药结核病(TB)发病率随时间的变化趋势,以及肺结核(PTB)和肺外结核(EPTB)耐药模式的差异。
纳入2006年至2013年所有培养确诊为TB的患者。
共纳入1745例患者:1431例(82.0%)为新发病例,314例(18.0%)为既往治疗病例;1610例(92.3%)诊断为PTB,135例(7.7%)诊断为EPTB。新发病例中耐多药(MDR)和广泛耐药(XDR)TB的检出率分别为5.8%和2.0%,既往治疗病例中分别为20.1%和8.6%。研究期间MDR TB发病率显著下降,而既往治疗病例中MDR和XDR TB发病率显著下降。PTB和EPTB之间未检测到耐药率差异。
在一家私立转诊医院,TB耐药率,尤其是MDR TB耐药率仍然很高,且2006年至2013年耐药率未显著下降。这一发现强调需要进行一项关于耐药TB患病率的全国性调查,以获取韩国包括私营部门在内的最准确和最新的耐药状况。